NCT07602088
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Spitalul Universitar de Urgenta Bucuresti Bucharest, Romania
Clinical trial condition
Leukemia, Lymphocytic, Chronic, B-Cell
Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.
45 public trials
6 recruiting studies
Leukemia, Lymphocytic, Chronic, B-Cell trial results
NCT06299540
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Institut Universitaire du Cancer Toulouse Oncopole Toulouse, France
- Conditions
- CLL, Chronic Disease, Disease Attributes, +18 more
- Locations
-
- Highlands Oncology Group ( Site 5405) Springdale, Arkansas, United States
- MemorialCare Health System - Long Beach Medical Center ( Site 5421) Long Beach, California, United States
- Memorial Hospital West ( Site 5410) Pembroke Pines, Florida, United States
- Oregon Health and Science University ( Site 5425) Portland, Oregon, United States
NCT06364423
- Conditions
- Acute Lymphoblastic Leukemia, B-Lymphocytic Leukemia, Chronic, B-cell Chronic Lymphocytic Leukemia, +20 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT00626496
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT02869529
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
- Locations
-
- Linear Clinical Research Ltd Nedlands, Australia
- Scientia Clinical Research Randwick, Australia
- Ghent University Hospital Ghent, Belgium
- Hopital Claude Huriez Lille, France
NCT03462719
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Norton Cancer Institute Louisville, Kentucky, United States
- John Theurer Cancer Center Hackensack, New Jersey, United States
- Novant Health Charlotte, North Carolina, United States
- Institut - Jules Bordet Anderlecht, Belgium
Active, not recruiting
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT05963074
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- The Oncology Institute Clinical Research Cerritos, California, United States
- Cancer and Blood Specialty Clinic Los Alamitos, California, United States
- SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
- Providence Medical Foundation Santa Rosa, California, United States
Active, not recruiting
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
NCT05424822
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- City of Hope Duarte, California, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States